UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - NYSE:UTI - US9139151040 - Common Stock
29.65 USD
+1.34 (+4.73%)
29.95 USD
+0.3 (+1.01%)
UTI gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 78 industry peers in the Diversified Consumer Services industry. While UTI belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UTI is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make UTI suitable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year UTI was profitable.
UTI had a positive operating cash flow in the past year.
UTI had positive earnings in each of the past 5 years.
In the past 5 years UTI always reported a positive cash flow from operatings.
1.2 Ratios
UTI's Return On Assets of 8.52% is fine compared to the rest of the industry. UTI outperforms 79.49% of its industry peers.
With an excellent Return On Equity value of 20.57%, UTI belongs to the best of the industry, outperforming 87.18% of the companies in the same industry.
The Return On Invested Capital of UTI (10.86%) is better than 84.62% of its industry peers.
UTI had an Average Return On Invested Capital over the past 3 years of 5.11%. This is below the industry average of 9.53%.
The 3 year average ROIC (5.11%) for UTI is below the current ROIC(10.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROIC | 10.86% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 7.79%, UTI is in the better half of the industry, outperforming 69.23% of the companies in the same industry.
In the last couple of years the Profit Margin of UTI has grown nicely.
The Operating Margin of UTI (10.44%) is better than 69.23% of its industry peers.
In the last couple of years the Operating Margin of UTI has grown nicely.
UTI's Gross Margin of 49.65% is in line compared to the rest of the industry. UTI outperforms 55.13% of its industry peers.
In the last couple of years the Gross Margin of UTI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% |
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UTI is still creating some value.
Compared to 1 year ago, UTI has more shares outstanding
UTI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, UTI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.86 indicates that UTI is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 3.86, UTI belongs to the best of the industry, outperforming 85.90% of the companies in the same industry.
The Debt to FCF ratio of UTI is 0.99, which is an excellent value as it means it would take UTI, only 0.99 years of fcf income to pay off all of its debts.
UTI has a better Debt to FCF ratio (0.99) than 84.62% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that UTI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.23, UTI is in line with its industry, outperforming 57.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Altman-Z | 3.86 |
ROIC/WACC1.28
WACC8.46%
2.3 Liquidity
UTI has a Current Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
UTI has a Current ratio of 1.00. This is comparable to the rest of the industry: UTI outperforms 44.87% of its industry peers.
UTI has a Quick Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
UTI's Quick ratio of 1.00 is in line compared to the rest of the industry. UTI outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 128.00% over the past year.
The Earnings Per Share has been growing by 28.35% on average over the past years. This is a very strong growth
Looking at the last year, UTI shows a quite strong growth in Revenue. The Revenue has grown by 14.56% in the last year.
Measured over the past years, UTI shows a quite strong growth in Revenue. The Revenue has been growing by 17.19% on average per year.
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
3.2 Future
The Earnings Per Share is expected to grow by 12.50% on average over the next years. This is quite good.
UTI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.46% yearly.
EPS Next Y44.42%
EPS Next 2Y12.22%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue Next Year14.42%
Revenue Next 2Y11.29%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
UTI is valuated quite expensively with a Price/Earnings ratio of 26.01.
UTI's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of UTI to the average of the S&P500 Index (26.28), we can say UTI is valued inline with the index average.
A Price/Forward Earnings ratio of 31.82 indicates a quite expensive valuation of UTI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UTI is on the same level as its industry peers.
UTI is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 33.61, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.01 | ||
| Fwd PE | 31.82 |
4.2 Price Multiples
UTI's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, UTI is valued a bit cheaper than 65.38% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.59 | ||
| EV/EBITDA | 12.47 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UTI may justify a higher PE ratio.
UTI's earnings are expected to grow with 12.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y12.22%
EPS Next 3Y12.5%
5. Dividend
5.1 Amount
No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.65
+1.34 (+4.73%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.48%
Inst Owner Change2.29%
Ins Owners2.24%
Ins Owner Change-1.76%
Market Cap1.61B
Revenue(TTM)809.53M
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (28.77%)
Short Float %3.62%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.46%
EPS NQ rev (3m)-21%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)1.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.01 | ||
| Fwd PE | 31.82 | ||
| P/S | 1.99 | ||
| P/FCF | 21.59 | ||
| P/OCF | 14.97 | ||
| P/B | 5.26 | ||
| P/tB | 6.19 | ||
| EV/EBITDA | 12.47 |
EPS(TTM)1.14
EY3.84%
EPS(NY)0.93
Fwd EY3.14%
FCF(TTM)1.37
FCFY4.63%
OCF(TTM)1.98
OCFY6.68%
SpS14.88
BVpS5.64
TBVpS4.79
PEG (NY)0.59
PEG (5Y)N/A
Graham Number12.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROCE | 15.21% | ||
| ROIC | 10.86% | ||
| ROICexc | 13.78% | ||
| ROICexgc | 15.4% | ||
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% | ||
| FCFM | 9.23% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 87.82% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 11.6 | ||
| Cash Conversion | 88.25% | ||
| Profit Quality | 118.43% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.86 |
F-Score6
WACC8.46%
ROIC/WACC1.28
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y44.42%
EPS Next 2Y12.22%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
Revenue Next Year14.42%
Revenue Next 2Y11.29%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y30.39%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 5 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Fairly Valued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 26.01 and the Price/Book (PB) ratio is 5.26.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to grow by 44.42% in the next year.